Stay updated on VELIA Clinical Trial: Veliparib in Ovarian Cancer
Sign up to get notified when there's something new on the VELIA Clinical Trial: Veliparib in Ovarian Cancer page.

Latest updates to the VELIA Clinical Trial: Veliparib in Ovarian Cancer page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now includes additional data-sharing information and links to the Statistical Analysis Plan and Study Protocol, expanding context for researchers, and an error page indicating an outage was removed, restoring access to the study record.SummaryDifference100%

- Check20 days agoChange DetectedThe page footer now lists Revision: v3.6.5, replacing the previous v3.6.4. This indicates a site revision update.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedFooter now shows Revision: v3.6.4, replacing v3.6.3, indicating a template update rather than a change to study content.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a minor platform/documentation update.SummaryDifference0.0%

- Check63 days agoChange DetectedA new bibliographic reference (Lafferty et al., 2026) was added to the Publications section, and the revision history shows an update to v3.6.2 with the removal of the prior v3.6.0 tag.SummaryDifference0.0%

- Check78 days agoChange DetectedEnrollment status now shows 'No longer looking for participants,' indicating enrollment is closed. The page also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment header formatting.SummaryDifference0.2%

Stay in the know with updates to VELIA Clinical Trial: Veliparib in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the VELIA Clinical Trial: Veliparib in Ovarian Cancer page.